View ValuationBio Planet 将来の成長Future 基準チェック /06現在、 Bio Planetの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Consumer Retailing 収益成長10.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.お知らせ • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.お知らせ • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025お知らせ • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.お知らせ • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).お知らせ • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.お知らせ • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.お知らせ • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.お知らせ • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Bio Planet は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:8WS - アナリストの将来予測と過去の財務データ ( )PLN Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20253116N/AN/AN/A9/30/2025302513N/A6/30/2025293435N/A3/31/2025284335N/A12/31/2024279246N/A9/30/2024272145N/A6/30/2024265145N/A3/31/2024262145N/A12/31/2023255146N/A9/30/20232401415N/A6/30/20232280116N/A3/31/20232140-915N/A12/31/20222011-1112N/A9/30/20222020-113N/A6/30/20222012-100N/A3/31/20222033-12N/A12/31/2021205403N/A9/30/20212055-43N/A6/30/20212065-63N/A3/31/20212076-63N/A12/31/20202045-53N/A9/30/20201915-13N/A6/30/2020181426N/A3/31/2020168325N/A12/31/2019153225N/A9/30/20191461N/A5N/A6/30/20191411N/A2N/A3/31/20191340N/A1N/A12/31/20181280N/A3N/A9/30/20181260N/A2N/A6/30/20181250N/A2N/A3/31/20181250N/A3N/A12/31/20171231N/A1N/A9/30/20171211N/A2N/A6/30/20171212N/A2N/A3/31/20171192N/A2N/A12/31/20161131N/A2N/A9/30/20161081N/A2N/A6/30/20161021N/A0N/A3/31/2016941N/A-1N/A12/31/2015862N/A0N/A9/30/2015792N/A0N/A6/30/2015732N/A3N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 8WSの予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 8WSの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 8WSの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 8WSの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 8WSの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 8WSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YConsumer-retailing 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 08:22終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bio Planet S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.
お知らせ • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.
お知らせ • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025
お知らせ • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.
New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).
New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.
お知らせ • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024
Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).
New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).
Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).
New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).
New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
お知らせ • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.
Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).
Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.
お知らせ • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023
Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.
お知らせ • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.
Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.
Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.
お知らせ • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.